Unrecognized hypoglycemia due to maltodextrin interference with bedside glucometry

Journal of Medical Toxicology

Volumn 5, Issue 1, 2009, Pages 20-23

  Kirrane, Barbara M ^a   Duthie, Elizabeth A ^b   Nelson, Lewis S ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypoglycemia; Maltodextrin; Point of care glucometers

Indexed keywords

MALTODEXTRIN; ANTIDIABETIC AGENT; INSULIN; POLYSACCHARIDE;

AGED; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CASE REPORT; DIAGNOSTIC ERROR; ENTERIC FEEDING; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LABORATORY TEST; MALE; NASOGASTRIC TUBE; OUTCOME ASSESSMENT; POINT OF CARE TESTING; ARTIFACT; BLOOD; CHEMICALLY INDUCED DISORDER; FATALITY; HOSPITAL INFORMATION SYSTEM; HYPERGLYCEMIA; INSTRUMENTATION; MEDICATION ERROR; METABOLISM; MONITORING; PREDICTION AND FORECASTING; REPRODUCIBILITY;

AGED; ARTIFACTS; BLOOD GLUCOSE; DIAGNOSTIC ERRORS; ENTERAL NUTRITION; FATAL OUTCOME; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MEDICATION ERRORS; MONITORING, PHYSIOLOGIC; POINT-OF-CARE SYSTEMS; POLYSACCHARIDES; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 65249115792     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/BF03160976     Document Type: Article

References (12)

1. US Food and Drug Administration, [web page on the Internet]. Important safety information on interference with blood glucose measurement following use of parenteral maltose/parenteral galactose/oral-xylose-containing products [cited 2007 November 19]. Available at: http://www.fda.gov/cber/safety/maltose110405.htm
2. Ghys T, Goedhuys W, Spincemaille K, Gorus F, Gerlo E. Plasma-equivalent glucose at the point-of-care: evaluation of Roche Accu-Chek Inform and Abbott Precision PCx glucose meters. Clin Chim Acta 2007;386:63-68.
3. Newman JD, Ramsden CA, Balazs NDH. Monitoring neona-tal hypoglycemia with the Accu-chek Advantage II glucose meter: The cautionary tale of galactosemia. Clin Chem 2002;48:2071.
4. Apperloo JJ, Vader HL. A quantitative appraisal of interfer-ence by icodextrin metabolites in point-of-care glucose analyses. Clin Chem Lab Med 2005;43:314-318.
5. Mehmet S, Quan G, Thomas S, et al. Important causes of hypoglycemia in patients with diabetes on peritoneal dialysis. Diabet Med 2001;18:679-682.
6. Riley SG, Chess J, Donovan KL, et al. Spurious hypergly-caemia and icodextrin in peritoneal dialysis fluid. BMJ 2003; 327:608-609.
7. Janssen W, Harff G, Caers M, et al. Positive interferences of icodextrin metabolites in some enzymatic glucose methods. Clin Chem 1998;44:2379-2380.
8. Wang R, Skoufos L, Martis L. Glucose monitoring for diabetic patients using icodextrin. Perit Dial Int 2004;24: 296-297.
9. ISMP Medication Safety Alert. Be aware of false glucose results with point-of-care testing. 2005;10:1-3.
10. Sutherland LR, Verhoef M, Wallace JL, et al. A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet 1994;343:998-1000.
11. Sjöstedt Zsigmond C, Hannestad U, Franzén L, et al. Atrophic gastritis is associated with increased sucrose permeability related to chronic inflammation. Digestion 2005; 72:201-206.
12. Asano T, Greenberg BZ, Wittmers PV, et al. Xylitol, a partial homologue of alpha-D-glucopyranose: a potent stimulator of insulin release in dogs. Endocrinology 1977;100: 339-345.